Leases - Narrative (Details) $ in Thousands, squareFeet in Millions		1 Months Ended	3 Months Ended			6 Months Ended
	Oct. 26, 2023 USD ($) property	Jul. 31, 2024 ft² squareFeet	Jun. 30, 2024 USD ($) lease	Jun. 30, 2023 USD ($)	Mar. 31, 2023 USD ($) lease	Jun. 30, 2024 USD ($) lease	Jun. 30, 2023 USD ($)	Dec. 31, 2023 USD ($)
Lessor, Lease, Description [Line Items]
Initial direct costs			$ 172,000			$ 172,000		$ 172,000
Straight line rent receivable, net of allowances			319,000			319,000		$ 310,000
Straight-line rent receivable						22,545	$ 5,431
Litigation settlement, amount awarded from other party				$ 2,000
Proceeds from insurance recovery				2,000
Rental and related revenues			546,781	409,967		1,008,814	802,398
Fixed income from operating leases			$ 404,225	$ 311,663		$ 747,639	$ 606,179
Operating lease, percentage of annual lease escalations			0.025			0.025
Subsequent Event
Lessor, Lease, Description [Line Items]
Operating lease, area of square feet renewed | squareFeet		2
Operating lease, percentage of annual lease escalations		0.030
Area of square feet with early termination right | ft²		200,000
Sorrento Therapeutics, Inc.
Lessor, Lease, Description [Line Items]
Straight-line rent receivable					$ 9,000
Number of leases | lease					4	4
Number of leases approved | lease			3
Graphite Bio, Inc.
Lessor, Lease, Description [Line Items]
Property count | property	1
Rental and related revenues	$ 37,000
Termination fees	21,000
Fixed income from operating leases	$ 16,000